Extended HPV Genotyping for Risk Assessment of Cervical Intraepithelial Neoplasia Grade 2/3 or Worse in a Cohort Study

Xiao Li,Xuan Rao,Ming-Jing Wei,Wei-Guo Lu,Xing Xie,Xin-Yu Wang
DOI: https://doi.org/10.6004/jnccn.2022.7032
IF: 12.6934
2022-01-01
Journal of the National Comprehensive Cancer Network
Abstract:Background: We sought to identify the absolute risk of specific HPV genotype for cervical intraepithelial neoplasia grade 2/3 or worse (CIN2+/3+) and to develop a risk-based management strategy in an HPV-positive population. Methods: HPV genotyping was performed based on a 3-year cervical cancer screening cohort. The study end-points were histologic CIN2+/3+. The prevalence of specific HPV genotype was calculated by minimum, any type, and hierarchical at-tribution estimate. The absolute CIN2+/3+ risks of specific HPV ge-notype were estimated and risk-based management strategy was established according to the American Society for Colposcopy and Cervical Pathology guideline. The efficacy of conventional and risk -based management strategies for non-16/18 HPVs were further eval-uated. Results: Eligible data were available for 8,370 women with a median age of 48 years (interquartile range, 42 & ndash;53 years). At base-line, there were 1,062 women with HPV-positive disease, including 424 with multiple and 639 with single infections. CIN2+/3+ cases represented 113/74, 23/8, 20/7, and 52/31 patients at baseline and first-, second-, and third-year visits, respectively. Women with multi-ple HPV infections at baseline were more prone to persistent infec-tion than those with single infection (P <.0001). HPV16 and HPV52 were the top 2 ranking among baseline and 3-year cumulative CIN2+/3+ cases. Based on the absolute risk of specific HPV geno-type combined with cytology for CIN2+/3+, all non-16/18 HPVs were divided into 4 risk-stratified groups. Compared with conven-tional strategy, the risk-based strategy had higher specificity (P=.0000) and positive predictive value (P=.0322) to detect CIN3+ and needed fewer colposcopies for each CIN3+ case. Conclusions: Based on our study findings, we propose a new extended HPV geno-typing protocol, which would provide a better strategy for achieving precise risk-based management of HPV-positive populations. J Natl Compr Canc Netw 2022;20(8):906 & ndash;914.e10 doi: 10.6004/jnccn.2022.7032
What problem does this paper attempt to address?